International Journal of Hematology and Oncology
2023, Vol 33, Num 4 Page(s): 165-174
| Back | Table of Contents | Turkish Abstract | PDF | Mail to Author | |
THE ROLE OF EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITORS IN THE NON-SMALL CELL LUNG CANCER TREATMENT
Özden ALTUNDAĞ1, Kadri ALTUNDAĞ2
1Department of Thoracic/Head&Neck Cancer Medicine The University of Texas M .D. Anderson Cancer Center, Houston, Texas, USA
2Hacettepe Üniversitesi Tıp Fakültesi İç Hastalıkları Anabilim Dalı, Medikal Onkoloji Bolümü, ANKARA
3Department of Breast Medical Oncology The University of Texas M .D. Anderson Cancer Center, Houston, Texas, USA
Keywords: Non-small cell lung cancer, Epidermal growth factor receptor inhibitor, Tyrosine kinase, Gefitinib, Erlotinib, Cetuximab
Recently significant progress has been achieved in the targeted treatment of lung cancer. In this review we summarize recent developments in epidermal growth factor receptor inhibitors for non-small cell lung cancer treatment in the view of current pertinent literature.
Özden ALTUNDAĞ1, Kadri ALTUNDAĞ2
1Department of Thoracic/Head&Neck Cancer Medicine The University of Texas M .D. Anderson Cancer Center, Houston, Texas, USA
2Hacettepe Üniversitesi Tıp Fakültesi İç Hastalıkları Anabilim Dalı, Medikal Onkoloji Bolümü, ANKARA
3Department of Breast Medical Oncology The University of Texas M .D. Anderson Cancer Center, Houston, Texas, USA
Keywords: Non-small cell lung cancer, Epidermal growth factor receptor inhibitor, Tyrosine kinase, Gefitinib, Erlotinib, Cetuximab
Recently significant progress has been achieved in the targeted treatment of lung cancer. In this review we summarize recent developments in epidermal growth factor receptor inhibitors for non-small cell lung cancer treatment in the view of current pertinent literature.
| Back | Table of Contents | Turkish Abstract | PDF | Mail to Author | |